- Blake assumes leadership of U.S. corporate functions from Greg Babe
- Also holds roles of Bayer HealthCare Representative U.S.A. and Head of Region U.S. Bayer HealthCare Pharmaceutical
The Management Board of Bayer AG announced today that on July 1, 2012, Philip Blake will become Senior Bayer Representative (SBR) USA, following a common company practice of assigning this oversight role to a senior executive already holding a significant business role or roles within the region. In this new role, Blake assumes leadership of Bayer corporate operations in the U.S. from Greg Babe, who recently announced his planned retirement from Bayer. In 2011, Bayer's U.S. operations recorded annual sales of $9,791 million.
Blake has also been named Bayer HealthCare Representative U.S.A., and will maintain his position as U.S. Region head of Bayer HealthCare Pharmaceuticals, the U.S.-based specialty pharmaceuticals division of Bayer HealthCare LLC, a subsidiary of Bayer AG. In the U.S., Bayer HealthCare Pharmaceuticals provides products for General Medicine, Hematology, Neurology, Oncology and Women's Healthcare. With construction underway for a new consolidated U.S. Bayer HealthCare site in Whippany, N.J., Blake will maintain his primary office in that location.
"Phil Blake is a highly valued and respected leader at Bayer," said Dr. Richard Pott, member of the Management Board of Bayer AG. "Having been with Bayer for more than 30 years, he brings a wealth of experience to this new role."
Blake was previously head of Bayer Inc., a Canadian subsidiary of Bayer AG, and head of Bayer HealthCare in Canada. In his 30-year career with Bayer, Blake has held leadership positions around the world focusing on global strategic product marketing, business development, clinical planning, product development and sales management.
Blake attended Bristol University and Oxford University Business School in the United Kingdom, with extended business training at INSEAD Fontainbleu in Paris, France, and the Wharton Business School in Philadelphia. He is also a Chartered Corporate Director – earning this designation in 2006 from the Directors College at the DeGroote School of Business, McMaster University. He is married and has two children.
About Bayer Corporation
Bayer Corporation, headquartered in Pittsburgh, is a subsidiary of Bayer AG, an international health care, nutrition and high-tech materials group based in Leverkusen, Germany. As an inventor company, it sets trends in research-intensive areas. The company's products and services are designed to benefit people and improve their quality of life. The Corporation is committed to the principles of sustainable development and to its role as a socially and ethically responsible corporate citizen. Economy, ecology and social responsibility are corporate policy objectives of equal rank. In North America, Bayer had 2011 net sales of EUR 8,177 million ($11,366 million) and employed 15,800 at year-end. For more information, go to www.bayerus.com.
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conformthem to future events or developments.
Contacts:
Bayer Corporation
Katie Kirkpatrick, 412-777-5200
E-mail: katie.kirkpatrick@bayer.com
or
Rosemarie
Yancosek, 973-305-5213
E-mail : rosemarie.yancosek@bayer.com
or
Find
more information at www.BayerUS.com.
